March 23, 2025

2 Minutes
Medicine

Domain Therapeutics progresses drug candidate for inflammatory diseases

Domain Therapeutics has announced it has nominated and is progressing DT-9046, a candidate with “game-changing” potential in multiple inflammatory disease markets, including atopic dermatitis (AD), inflammatory bowel disease (IBD), arthritis but also neuroinflammation including migraine....
Read More